Medical Breakthroughs
FDA’s PCCP: De-Risking Cardiac AI for Billion Dollar Exits
The promise of adaptive clinical algorithms in healthcare AI is immense, offering the potential for continuous…
Medical Breakthroughs
Medical Breakthroughs
Federal AI Standards: The New VC Litmus Test for Digital Health
The investment field for digital health is shifting dramatically, moving from a “move fast and break…
Medical Breakthroughs
AI Diabetic Retinopathy: Data-Driven Safety & Accuracy
Autonomous AI diagnostic systems promise to revolutionize healthcare delivery, expanding access to critical screenings in underserved…
Medical Breakthroughs
Cardiac AI Reimbursement: Who Wins (and Loses) Billions?
The seismic shift in healthcare reimbursement, moving from a volume-centric fee-for-service model to outcome-based value-based care,…
Medical Breakthroughs
De-Risking Cardiac AI: Federal Validation for Adaptive ML Models
The rapid evolution of artificial intelligence in healthcare presents a unique regulatory paradox: the very adaptability…
Medical Breakthroughs
AI in Breast Screening: Workload Reduction or Hype?
The promise of artificial intelligence in breast cancer screening often paints a picture of dramatically reduced…
Medical Breakthroughs
Big Tech’s Healthcare AI: Following the Money to Lasting Value
The investment landscape for healthcare AI is a complex tapestry, with venture capital flows raising critical…
Medical Breakthroughs
Generative AI in Clinical Documentation: Unpacking Safety Risks
Generative AI is flooding clinical documentation, promising to finally kill the administrative busywork that dogs clinicians.…
Medical Breakthroughs
Cardiac AI: Is Your Investment Validated?
The promise of artificial intelligence in radiology is immense, offering the potential for earlier diagnoses, improved…
Medical Breakthroughs
FDA 510(k) Fuels AI Funding: De-Risking or De-Validating?
The narrative arc of venture capital in healthcare AI has fundamentally shifted. Regulatory clearance is no…